Published in Transplant Proc on June 01, 2003
Phage treatment of human infections. Bacteriophage (2011) 2.77
Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother (2006) 1.58
Isolation and characterisation of KP34--a novel φKMV-like bacteriophage for Klebsiella pneumoniae. Appl Microbiol Biotechnol (2011) 1.30
Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci (2012) 1.00
Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity. Cancer Gene Ther (2012) 0.98
Effects of bacteriophages on free radical production and phagocytic functions. Med Microbiol Immunol (2006) 0.97
Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15. Antimicrob Agents Chemother (2012) 0.92
Bacteriophages and phage-derived proteins--application approaches. Curr Med Chem (2015) 0.83
Bacteriophage Procurement for Therapeutic Purposes. Front Microbiol (2016) 0.82
Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases. Front Microbiol (2016) 0.81
Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp. Infect Immun (1980) 1.62
Pyrrolidonyl peptidase in bacteria: a new colorimetric test for differentiation of enterobacteriaceae. J Gen Microbiol (1970) 1.46
Disturbances of T-cell interactions with endothelium and the extracellular matrix proteins in a patient with Takayasu arteritis. J Intern Med (1994) 1.40
Serologic relationship of fimbriae among Enterobacteriaceae. Arch Immunol Ther Exp (Warsz) (1977) 1.32
The influence of external factors on bacteriophages--review. Folia Microbiol (Praha) (2011) 1.22
Pyrrolidonyl peptidase in bacteria. The enzyme from Bacillus subtilis. Eur J Biochem (1969) 1.12
Bacteriophage therapy of bacterial infections: an update of our institute's experience. Arch Immunol Ther Exp (Warsz) (2000) 1.11
Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis--case report. Folia Microbiol (Praha) (2009) 1.05
Studies on virulence of Shigella flexneri. Arch Immunol Ther Exp (Warsz) (1978) 0.98
Isolation, purification and physico-chemical characteristic of Shigella sonnei phase I free endotoxin. Eur J Biochem (1970) 0.93
The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. Transplant Proc (2007) 0.92
The chemical nature of Shigella flexneri group antigen factor 6. Pathol Microbiol (Basel) (1971) 0.91
Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin. Acta Microbiol Acad Sci Hung (1974) 0.90
Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch Immunol Ther Exp (Warsz) (2000) 0.89
Hemagglutinating properties of Shigella bacilli. Arch Immunol Ther Exp (Warsz) (1967) 0.88
Pyrrolidonyl peptidase activity: a simple test for differentiating staphylococci. J Gen Microbiol (1972) 0.88
Possible association between phages, Hoc protein, and the immune system. Arch Virol (2005) 0.86
Concerning the classification of Shigella flexneri 6 bacilli. Arch Immunol Ther Exp (Warsz) (1967) 0.85
[Successful treatment with bacteriophage in purulent cerebrospinal meningitis in a newborn]. Neurol Neurochir Pol (1999) 0.84
Chemical studies on the specific fragment of Shigella sonnei phase II. Eur J Biochem (1968) 0.82
Cell culture preparation of human parathyroid cells for allotransplantation without immunosuppression. Transplant Proc (1996) 0.81
Increased expression of adhesion molecule CD18 (LFA-1beta) on the leukocytes of peripheral blood in patients with acute ischemic stroke. Acta Neurol Scand (1998) 0.81
Studies on gamma-glutamyl peptidase from Pseudomonas aeruginosa. Arch Immunol Ther Exp (Warsz) (1970) 0.81
Hafnia alvei lipopolysaccharides: isolation, sugar composition and SDS-PAGE analysis. FEMS Microbiol Immunol (1988) 0.80
The effect of calf thymus extract (TFX) on human and mouse hemopoiesis. Thymus (1981) 0.80
[Some aspects of immune response in toxoplasmosis]. Przegl Epidemiol (2001) 0.80
Oral heparin in the treatment of rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) (1995) 0.80
Glycyl peptidase in human serum and tissues. FEBS Lett (1969) 0.79
Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker--case report. Folia Microbiol (Praha) (2006) 0.79
Molecular modification of T4 bacteriophage proteins and its potential application - review. Folia Microbiol (Praha) (2009) 0.79
Cultured parathyroid cell transplantation without immunosuppression in the treatment of surgical hypoparathyroidism. Transplant Proc (1994) 0.79
Heparin enhances generation of natural killer activity in vitro. Arch Immunol Ther Exp (Warsz) (1994) 0.79
Apoptosis of T cells in the first trimester human decidua. Am J Reprod Immunol (1998) 0.79
Intravenous immunoglobulin therapy influences T cell adhesion to extracellular matrix in women with a history of recurrent spontaneous abortions. Am J Reprod Immunol (2000) 0.79
An optimal assay of human B cell proliferation in vitro. J Immunol Methods (1987) 0.78
Human peripheral blood CD8+ CD28- T cells of renal allograft recipients do not express FOXP3 protein. Transplant Proc (2011) 0.78
Possible association of cytotoxic T-lymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant. Transplant Proc (2006) 0.78
Use of a new phage preparation in prophylaxis and treatment of shigellosis. Acta Microbiol Acad Sci Hung (1974) 0.78
[Cutaneous larva migrans in children in a school of center-western Brazil]. Rev Saude Publica (2000) 0.78
The effect of azathioprine on terminal differentiation of human B lymphocytes. Immunopharmacology (1983) 0.77
Protective properties of peptidoglycan associated protein of Shigella flexneri. Arch Immunol Ther Exp (Warsz) (1984) 0.77
Studies on specificity of protection induced by immunization with outer membrane proteins of Shigella. Arch Immunol Ther Exp (Warsz) (1985) 0.77
Gamma delta + T cells in Wilson's disease. Int J Clin Lab Res (1996) 0.77
Immunosuppressive action of low-dose heparin. Effect on skin allograft survival. Transplantation (1990) 0.77
Phagocytic and bactericidal properties of macrophages of mice immunized with outer membrane proteins (OMP) of Shigella. Arch Immunol Ther Exp (Warsz) (1988) 0.77
Transfer of immunity by means of spleen cells from mice immunized with outer membrane proteins of Shigella flexneri. Arch Immunol Ther Exp (Warsz) (1985) 0.77
HLA antigens and intracranial aneurysms. Acta Neurochir (Wien) (1992) 0.77
Autoimmune neutropenia after renal transplantation. Transplantation (1989) 0.77
Beta 3 integrin expression on T cells from renal allograft recipients. Transplant Proc (2006) 0.77
Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice. Immunology (1990) 0.77
Phages in the global fruit and vegetable industry. J Appl Microbiol (2014) 0.77
Chemical studies on the specific fragment of Shigella sonnei phase I. Biochim Biophys Acta (1967) 0.77
Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses. Immunopharmacology (1990) 0.77
[Immunology of ulcerative colitis--interactions of T lymphocytes with extracellular matrix proteins]. Pol Arch Med Wewn (1997) 0.77
In vitro humoral responses of renal allograft recipients. Transplant Proc (1987) 0.77
Induction of tumor necrosis factor and interleukin 6 by outer membrane proteins of Shigella in spleen cells and macrophages of mice. Arch Immunol Ther Exp (Warsz) (1993) 0.76
Humoral response in mice immunized with outer membrane proteins of Shigella flexneri. Arch Immunol Ther Exp (Warsz) (1986) 0.76
Allogeneic sensitization alters T-cell reactivity to extracellular matrix proteins in prospective transplant recipients. Transplant Proc (1995) 0.76
Alterations of T-cell: extracellular matrix proteins interactions in psoriasis. Immunol Lett (1993) 0.76
Humoral response in mice immunized with outer membrane proteins of Hafnia alvei. Protective activity of anti-OMP-antibodies. Arch Immunol Ther Exp (Warsz) (1992) 0.76
New scheme of phage typing of Shigella flexneri. Arch Roum Pathol Exp Microbiol (1969) 0.76
Low dose heparin: efficacious treatment for chronic renal allograft rejection. Arch Immunol Ther Exp (Warsz) (1993) 0.76
Thymosin: an immunomodulator of antibody production in man. Immunology (1982) 0.76
Effect of FK 506 on B-cell responses. Transplant Proc (1991) 0.76
Studies on virulence of Shigella flexneri. Protective effect of outer membrane proteins. Arch Immunol Ther Exp (Warsz) (1981) 0.76
Cytotoxic and antitumor effect of fibrinogen-methotrexate conjugate. Cancer Lett (2000) 0.76
Immune abnormalities in aneurysmal subarachnoid haemorrhage patients: relation to delayed cerebral vasospasm. Scand J Immunol (2000) 0.76
Neutrophil functions in renal transplant recipients. Arch Immunol Ther Exp (Warsz) (1978) 0.76
Rejection-associated abnormalities of T-cell interactions with extracellular matrix. Transplant Proc (1995) 0.76
Involvement of beta2-microglobulin in CD69 expression on T cells. Arch Immunol Ther Exp (Warsz) (2001) 0.76
Abnormalities in T-cell-ECM interactions in cancer. Immunol Today (1996) 0.75
Enhanced clonability of human T lymphocytes caused by their culturing in vitro. Immunology (1981) 0.75
[Immunologic disorders in uremia]. Pol Arch Med Wewn (1974) 0.75
[The transamination reaction of the Roman snail's leg tissue with alpha ketoglutarate and pyruvate (author's transl)]. Ann Univ Mariae Curie Sklodowska Med (1973) 0.75
Antifungal activity of Wratizolin. Arch Immunol Ther Exp (Warsz) (1983) 0.75
Phage typing, colicin sensitivity and colicinogeny of Shigella flexneri 6. Arch Immunol Ther Exp (Warsz) (1967) 0.75
Cellular immunity in man assessed by indirect migration inhibition test using murine spleen leukocytes. Biomedicine (1973) 0.75
[Monitoring cellular immunity in patients following renal transplantation]. Pol Arch Med Wewn (1972) 0.75
The influence of hydrochloric acid on the cell wall of Shigella sonnei phase. I. Arch Immunol Ther Exp (Warsz) (1970) 0.75
Lysotypes of Shigella flexneri. Arch Immunol Ther Exp (Warsz) (1968) 0.75
Biological properties of Shigella sonnei endotoxins. Arch Immunol Ther Exp (Warsz) (1970) 0.75
Antibacterial activity of Wratizolin. Arch Immunol Ther Exp (Warsz) (1983) 0.75
Biological evaluation of Wratizolin penetration from ointments to the skin. Arch Immunol Ther Exp (Warsz) (1983) 0.75
Simultaneous transfer of two episomes, colicinogenic factor I and resistance transfer factor, present in the same donor. Arch Immunol Ther Exp (Warsz) (1966) 0.75
[Advances in internal immunology: transfer of cellular immunity. Clinical problems in theory and practice]. Pol Arch Med Wewn (1973) 0.75
Structural studies on D-specific polysaccharide of Shigella flexneri serotype 6. Eur J Biochem (1976) 0.75
Cellular immunity in man assessed by indirect migration inhibition test using murine spleen leukocytes. Biomedicine (1973) 0.75
Fimbriae and haemagglutinating properties in Edwardsiella and Levinea. Acta Microbiol Pol (1977) 0.75
Lipopolysaccharide immunoadsorbents and their application to affinity chromatography of O-antibodies and specific phages. FEBS Lett (1976) 0.75
[Effect of plasmids R on the changes in S. flexneri sensitivity to phages]. Med Dosw Mikrobiol (1983) 0.75
Transferable drug resistance of Escherichia coli isolated from infant diarrhoea. Acta Microbiol Pol (1979) 0.75
Histochemical and biochemical studies of glycyl peptidase and glycyl arylamidase. Acta Histochem (1971) 0.75
[Non-steroidal anti-inflammatory agents and the heart]. Wiad Lek (1986) 0.75
The immunologic properties of free endotoxin of Shigella sonnei. Arch Immunol Ther Exp (Warsz) (1970) 0.75
Multiple antibiotic resistance of Shigella flexneri 6. Arch Immunol Ther Exp (Warsz) (1967) 0.75
[Transfer of H2S plasmid from E. coli to Shigella]. Med Dosw Mikrobiol (1983) 0.75
[Advances of clinical immunology. Carcinoembryonic antigen (CEA)]. Pol Arch Med Wewn (1973) 0.75
Migration inhibition test based on the culture of spleen fragments: a quantitative analysis. Folia Biol (Praha) (1972) 0.75